These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30370856)

  • 1. Comparison of the Effects of Metoprolol and Bisoprolol on Lipid and Glucose Profiles in Cardiovascular Patients.
    Almeman AA; Beshir YA; Aldosary AH
    Curr Drug Saf; 2019; 14(1):27-30. PubMed ID: 30370856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of bisoprololal in hypertensive patients with cardiovascular disease and chronic obstructive pulmonary disease].
    Statsenko ME; Derevianchenko MV; Chernikov MV; Lopushkova IuE
    Kardiologiia; 2014; 54(1):48-54. PubMed ID: 24881311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
    Kayser A; Beck E; Hoeltzenbein M; Zinke S; Meister R; Weber-Schoendorfer C; Schaefer C
    J Hypertens; 2020 Feb; 38(2):354-361. PubMed ID: 31584512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the ECG Outcomes of Metoprolol and Bisoprolol.
    Almeman AA; Alharbi YO; Alwahhabi AS; Almutairi AA; Alnasr MY; Almesnid A
    Cardiovasc Hematol Agents Med Chem; 2023 Oct; ():. PubMed ID: 37909439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
    Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
    Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.
    Ashes C; Judelman S; Wijeysundera DN; Tait G; Mazer CD; Hare GM; Beattie WS
    Anesthesiology; 2013 Oct; 119(4):777-87. PubMed ID: 23820187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
    Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.
    Hefner G; Unterecker S; Shams ME; Wolf M; Falter T; Haen E; Hiemke C
    J Neural Transm (Vienna); 2015 Nov; 122(11):1609-17. PubMed ID: 25940834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
    Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol.
    Nozawa T; Taguchi M; Tahara K; Hashimoto Y; Igarashi N; Nonomura M; Kato B; Igawa A; Inoue H
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):713-20. PubMed ID: 16220080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].
    Haneda T; Ido A; Fujikane T; Tanaka H; Tanazawa S; Morimoto H; Kato J; Kanaya K; Honda H; Sakai H; Akita N; Hirayama T; Onodera S; Kikuchi K
    Nihon Ronen Igakkai Zasshi; 1998 Jan; 35(1):33-8. PubMed ID: 9564739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which is the preferred perioperative beta-blocker?].
    van Klei WA
    Ned Tijdschr Geneeskd; 2015; 159():A9798. PubMed ID: 26732221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
    Lin TY; Chen CY; Huang YB
    Int J Cardiol; 2017 Mar; 230():378-383. PubMed ID: 28041715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisoprolol and heart failure: new frontiers.
    Chopra HK
    Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure.
    Pasternak B; Mattsson A; Svanström H; Hviid A
    Int J Cardiol; 2015; 190():4-6. PubMed ID: 25912106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.